144 related articles for article (PubMed ID: 15953057)
1. Co-transplantation of autologous adult stem cells together with differentiated derivatives of human embryonic stem cells. A novel strategy to enhance the efficacy of autologous cell-transplantation therapy?
Heng BC; Cao T
Wound Repair Regen; 2005; 13(3):353-6. PubMed ID: 15953057
[No Abstract] [Full Text] [Related]
2. Potential benefits of co-transplanting autologous adult stem cells together with human embryonic stem cells or their differentiated derivatives.
Heng BC; Liu H; Cao T
Ann Clin Lab Sci; 2005; 35(1):3-6. PubMed ID: 15830703
[No Abstract] [Full Text] [Related]
3. Myocardial regenerative therapy: immunologic basis for the potential "universal donor cells".
Atoui R; Shum-Tim D; Chiu RC
Ann Thorac Surg; 2008 Jul; 86(1):327-34. PubMed ID: 18573459
[TBL] [Abstract][Full Text] [Related]
4. Homing of intravenously infused embryonic stem cell-derived cells to injured hearts after myocardial infarction.
Min JY; Huang X; Xiang M; Meissner A; Chen Y; Ke Q; Kaplan E; Rana JS; Oettgen P; Morgan JP
J Thorac Cardiovasc Surg; 2006 Apr; 131(4):889-97. PubMed ID: 16580449
[TBL] [Abstract][Full Text] [Related]
5. Stem cell transplantation for the treatment of myocardial infarction.
Dai W; Hale SL; Kloner RA
Transpl Immunol; 2005 Dec; 15(2):91-7. PubMed ID: 16412954
[TBL] [Abstract][Full Text] [Related]
6. Embryonic stem cell transplantation for the treatment of myocardial infarction: immune privilege or rejection.
Yuan X; Zhang H; Wei YJ; Hu SS
Transpl Immunol; 2007 Nov; 18(2):88-93. PubMed ID: 18005850
[TBL] [Abstract][Full Text] [Related]
7. Autologous cell based therapy for treating chronic infarct myocardium.
Tran N; Marie PY; Nloga J; Mascali F; Franken P; Lahoutte T; Li Y; Antunes L; El Jaafari A; Bensoussan D; Stoltz JF; Villemot JP
Clin Hemorheol Microcirc; 2005; 33(3):263-8. PubMed ID: 16215292
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs.
Li SR; Qi XY; Hu FL; Zhang JQ; Wang TH; Dang Y; Meng CL; Liu HL; Li YX; Wu D; Dong J; Xun LY; Gao LH; Jin FC
Chin Med J (Engl); 2008 Dec; 121(23):2403-9. PubMed ID: 19102957
[TBL] [Abstract][Full Text] [Related]
9. [Stem cell therapy in chronic heart failure].
Theiss HD; Franz WM
Med Klin (Munich); 2006 Jan; 101(1):77-81. PubMed ID: 16418819
[TBL] [Abstract][Full Text] [Related]
10. Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction.
Mathieu M; Bartunek J; El Oumeiri B; Touihri K; Hadad I; Thoma P; Metens T; da Costa AM; Mahmoudabady M; Egrise D; Blocklet D; Mazouz N; Naeije R; Heyndrickx G; McEntee K
J Thorac Cardiovasc Surg; 2009 Sep; 138(3):646-53. PubMed ID: 19698851
[TBL] [Abstract][Full Text] [Related]
11. Comments about possible use of human embryonic stem cell-derived cardiomyocytes to direct autologous adult stem cells into the cardiomyogenic lineage.
Heng BC; Haider HK; Sim EK; Cao T; Tong GQ; Ng SC
Acta Cardiol; 2005 Feb; 60(1):7-12. PubMed ID: 15779844
[TBL] [Abstract][Full Text] [Related]
12. Parthenogenetic embryonic stem cells derived from cryopreserved newborn mouse ovaries: a new approach to autologous stem cell therapy.
Xing F; Fang Z; Qin B; Li Y; Hou J; Chen X
Fertil Steril; 2009 Apr; 91(4):1238-44. PubMed ID: 18353322
[TBL] [Abstract][Full Text] [Related]
13. Stem cell therapy after myocardial infarction: ready for clinical application?
Engelmann MG; Franz WM
Curr Opin Mol Ther; 2006 Oct; 8(5):396-414. PubMed ID: 17078382
[TBL] [Abstract][Full Text] [Related]
14. Stem cell therapy: a new perspective in the treatment of patients with acute myocardial infarction.
Meyer GP; Wollert KC; Drexler H
Eur J Med Res; 2006 Oct; 11(10):439-46. PubMed ID: 17107878
[TBL] [Abstract][Full Text] [Related]
15. Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study.
Beitnes JO; Hopp E; Lunde K; Solheim S; Arnesen H; Brinchmann JE; Forfang K; Aakhus S
Heart; 2009 Dec; 95(24):1983-9. PubMed ID: 19833610
[TBL] [Abstract][Full Text] [Related]
16. Necrobiotic xanthogranuloma successfully treated with autologous stem cell transplantation.
Goede JS; Misselwitz B; Taverna C; Schanz U; Dispenzieri A; Hummel Y; Trüeb RM; Fehr J
Ann Hematol; 2007 Apr; 86(4):303-6. PubMed ID: 17216474
[TBL] [Abstract][Full Text] [Related]
17. Hemosiderin deposits confounds tracking of iron-oxide-labeled stem cells: an experimental study.
Rigol M; Solanes N; Roqué M; Farré J; Batlle M; Roura S; Bellera N; Prat-Vidal C; Sionis A; Ramírez J; Sitges M; Sanz G; Bayés-Genís A; Heras M
Transplant Proc; 2008 Dec; 40(10):3619-22. PubMed ID: 19100453
[TBL] [Abstract][Full Text] [Related]
18. Myocardial regeneration by embryonic stem cell transplantation: present and future trends.
Dai W; Kloner RA
Expert Rev Cardiovasc Ther; 2006 May; 4(3):375-83. PubMed ID: 16716098
[TBL] [Abstract][Full Text] [Related]
19. Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells.
Zenovich AG; Davis BH; Taylor DA
Handb Exp Pharmacol; 2007; (180):117-65. PubMed ID: 17554507
[TBL] [Abstract][Full Text] [Related]
20. Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction.
Meluzín J; Janousek S; Mayer J; Groch L; Hornácek I; Hlinomaz O; Kala P; Panovský R; Prásek J; Kamínek M; Stanícek J; Klabusay M; Korístek Z; Navrátil M; Dusek L; Vinklárková J
Int J Cardiol; 2008 Aug; 128(2):185-92. PubMed ID: 17764767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
